Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| WYY | WIDEPOINT CORP | $60.73M | 9,891,002 | 8.12% | 91.88% | Net Selling | |||
| VRNS | VARONIS SYSTEMS INC | $3.94B | 117,897,308 | 69.89% | 30.11% | Net Selling | |||
| MIRM | MIRUM PHARMACEUTICALS INC | $4.00B | 51,393,574 | 52.35% | 47.65% | Net Selling | Net Buying | ||
| CRTO | CRITEO SA | $1.02B | 52,549,158 | 84.84% | 11.65% | Net Selling | Net Buying | ||
| LXEO | LEXEO THERAPEUTICS INC | $755.42M | 72,987,327 | 67.63% | 9.87% | Net Selling | Net Selling | ||
| PTRN | PATTERN GROUP INC | $2.10B | 176,224,923 | 11.53% | 88.47% | Net Selling | Net Buying | ||
| CMPS | COMPASS PATHWAYS PLC | $611.63M | 96,017,044 | 57.78% | 29.77% | Net Selling | |||
| ANGO | ANGIODYNAMICS INC | $550.84M | 41,199,844 | 79.94% | 20.06% | Net Selling | Net Buying | ||
| RZLT | REZOLUTE INC | $164.13M | 92,727,532 | 44.64% | 55.36% | Net Buying | Net Buying | ||
| SGMT | SAGIMET BIOSCIENCES INC | $204.24M | 32,521,599 | 36.78% | 63.22% | Net Selling | Net Selling | ||
| CYBN | CYBIN INC | $165.38M | 23,033,127 | 40.05% | 0.00% | ||||
| ATR | APTARGROUP INC | $7.97B | 65,619,154 | 92.11% | 3.79% | Net Selling | Net Buying | ||
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.56B | 210,543,224 | 83.66% | 16.34% | Net Selling | Net Selling | ||
| ORIC | ORIC PHARMACEUTICALS INC | $783.01M | 97,389,279 | 83.26% | 16.74% | Net Selling | Net Selling | ||
| CGTX | COGNITION THERAPEUTICS INC | $135.94M | 88,274,258 | 24.09% | 29.21% | Net Selling | |||
| CNTX | CONTEXT THERAPEUTICS INC | $116.69M | 91,879,177 | 75.06% | 1.43% | Net Buying | |||
| PVLA | PALVELLA THERAPEUTICS INC | $1.18B | 11,836,490 | 57.88% | 42.12% | Net Buying | Net Buying | ||
| PAR | PAR TECHNOLOGY CORP | $1.51B | 40,591,032 | 84.66% | 15.34% | Net Selling | Net Buying | ||
| AKA | AKA BRANDS HOLDING CORP | $116.31M | 10,739,676 | 4.11% | 95.89% | Net Selling | Net Selling | ||
| IBIO | IBIO INC | $44.52M | 22,487,308 | 9.37% | 90.63% | Net Buying | |||
| TMHC | TAYLOR MORRISON HOME CORP | $5.84B | 97,725,037 | 96.23% | 2.98% | Net Selling | |||
| IDYA | IDEAYA BIOSCIENCES INC | $2.94B | 87,666,408 | 92.57% | 7.43% | Net Buying | |||
| KYMR | KYMERA THERAPEUTICS INC | $6.04B | 71,949,027 | 75.16% | 24.84% | Net Buying | Net Buying | ||
| LBRX | LB PHARMACEUTICALS INC | $533.05M | 25,299,102 | 71.88% | 28.12% | Net Buying | |||
| CRVO | CERVOMED INC | $70.32M | 9,252,719 | 2.96% | 97.04% | Net Buying | Net Buying | ||
| XOMA | XOMA ROYALTY CORP | $314.41M | 12,383,103 | 18.93% | 81.07% | Net Selling | Net Buying | ||
| CBC | CENTRAL BANCOMPANY INC | N/A | 238,442,900 | 0.00% | 2.15% | Net Buying | Net Buying | ||
| CEVA | CEVA INC | $509.90M | 24,017,805 | 69.22% | 30.78% | Net Buying | |||
| BETA | BETA TECHNOLOGIES INC | $7.00B | 229,030,133 | 0.00% | 27.50% | Net Buying | Net Buying | ||
| SMLR | SEMLER SCIENTIFIC INC | $271.82M | 15,159,895 | 62.99% | 37.01% | Net Buying | Net Buying | ||
| NOMD | NOMAD FOODS LTD | $1.89B | 147,700,000 | 73.07% | 0.00% | ||||
| ZYME | ZYMEWORKS INC | $2.04B | 74,836,534 | 52.65% | 47.35% | Net Buying | |||
| CHYM | CHIME FINANCIAL INC | $9.65B | 374,577,986 | 56.25% | 32.81% | Net Selling | Net Selling | ||
| LAKE | LAKELAND INDUSTRIES INC | $77.86M | 9,806,128 | 73.54% | 20.22% | Net Selling | Net Selling | ||
| MARA | MARA HOLDINGS INC | $3.85B | 378,184,353 | 73.45% | 10.52% | Net Selling | Net Selling | ||
| UPB | UPSTREAM BIO INC | $1.59B | 54,038,591 | 71.16% | 28.84% | ||||
| ALEC | ALECTOR INC | $152.81M | 109,151,472 | 61.21% | 38.79% | Net Selling | Net Selling | ||
| HTFL | HEARTFLOW INC | $2.60B | 85,158,719 | 52.02% | 35.50% | Net Buying | Net Buying | ||
| CTNM | CONTINEUM THERAPEUTICS INC | $342.60M | 29,182,511 | 59.89% | 9.25% | ||||
| BITF | BITFARMS LTD | $1.42B | 563,007,747 | 31.30% | 0.00% | ||||
| AIRG | AIRGAIN INC | $48.07M | 11,958,193 | 31.95% | 30.36% | Net Buying | Net Selling | ||
| NAVN | NAVAN INC | $3.76B | 248,644,065 | 0.00% | 100.00% | Net Buying | Net Buying | ||
| OMDA | OMADA HEALTH INC | $839.67M | 57,908,047 | 54.33% | 3.95% | Net Selling | Net Selling | ||
| T | AT&T INC | $171.21B | 7,089,449,495 | 64.44% | 0.31% | Net Selling | Net Selling | ||
| UDMY | UDEMY INC | $873.87M | 146,376,765 | 56.96% | 43.04% | Net Selling | Net Selling | ||
| ARVN | ARVINAS INC | $750.14M | 64,224,294 | 74.71% | 25.29% | Net Selling | Net Selling | ||
| VERI | VERITONE INC | $459.95M | 91,806,023 | 17.00% | 32.64% | Net Buying | |||
| FLR | FLUOR CORP | $6.59B | 161,182,507 | 90.86% | 3.54% | Net Selling | |||
| CMPX | COMPASS THERAPEUTICS INC | $887.53M | 177,862,102 | 78.76% | 21.24% | Net Selling | Net Selling | ||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $144.72M | 56,974,913 | 65.77% | 34.23% | Net Selling | Net Buying | ||
| VYX | NCR VOYIX CORP | $1.44B | 138,497,523 | 85.22% | 14.78% | Net Buying | Net Selling | ||
| TLX | TELIX PHARMACEUTICALS LTD | $2.61B | 334,724,485 | 0.25% | 0.00% | ||||
| AARD | AARDVARK THERAPEUTICS INC | $299.82M | 21,773,272 | 43.48% | 46.96% | Net Buying | Net Buying | ||
| EXOD | EXODUS MOVEMENT INC | $454.82M | 29,324,585 | 4.84% | 15.66% | Net Selling | Net Selling | ||
| GANX | GAIN THERAPEUTICS INC | $103.78M | 36,097,536 | 12.03% | 3.61% | ||||
| IRON | DISC MEDICINE INC | $3.02B | 37,750,162 | 57.86% | 42.14% | Net Selling | Net Selling | ||
| TNGX | TANGO THERAPEUTICS INC | $1.15B | 134,593,998 | 62.83% | 37.17% | Net Selling | Net Selling | ||
| CABA | CABALETTA BIO INC | $230.07M | 96,265,204 | 71.90% | 4.39% | ||||
| NKTR | NEKTAR THERAPEUTICS | $952.80M | 20,341,589 | 36.93% | 63.07% | Net Selling | Net Selling | ||
| ICUI | ICU MEDICAL INC | $3.58B | 24,686,660 | 72.01% | 27.99% | Net Buying | Net Selling | ||
| WVE | WAVE LIFE SCIENCES LTD | $2.67B | 167,181,784 | 74.84% | 25.16% | Net Buying | Net Buying | ||
| BHVN | BIOHAVEN LTD | $1.15B | 105,855,155 | 78.09% | 21.91% | Net Buying | Net Buying | ||
| ALIT | ALIGHT INC | $1.03B | 533,199,538 | 74.76% | 25.24% | Net Buying | Net Buying | ||
| AIRO | AIRO GROUP HOLDINGS INC | $251.37M | 31,303,834 | 24.89% | 34.70% | Net Selling | |||
| SYRE | SPYRE THERAPEUTICS INC | $2.59B | 77,592,130 | 71.39% | 28.61% | Net Selling | Net Selling | ||
| ANAB | ANAPTYSBIO INC | $1.36B | 27,688,470 | 42.69% | 57.31% | Net Buying | Net Selling | ||
| CARL | CARLSMED INC | $341.72M | 26,592,908 | 17.53% | 54.30% | Net Buying | |||
| BCC | BOISE CASCADE CO | $2.77B | 37,043,073 | 47.49% | 52.51% | Net Selling | |||
| IMUX | IMMUNIC INC | $68.92M | 120,284,724 | 35.49% | 13.20% | Net Buying | |||
| CYRX | CRYOPORT INC | $471.65M | 50,068,904 | 93.54% | 4.57% | Net Buying | Net Selling | ||
| ANRO | ALTO NEUROSCIENCE INC | $620.71M | 31,066,335 | 53.94% | 21.66% | ||||
| RCUS | ARCUS BIOSCIENCES INC | $2.37B | 107,973,536 | 64.20% | 35.80% | Net Buying | Net Selling | ||
| CTMX | CYTOMX THERAPEUTICS INC | $677.74M | 169,435,395 | 81.09% | 12.77% | Net Selling | Net Selling | ||
| OTLY | OATLY GROUP AB | $337.12M | 606,332,281 | 0.54% | 0.00% | ||||
| IRD | OPUS GENETICS INC | $137.93M | 68,964,208 | 5.83% | 94.17% | Net Selling | Net Selling | ||
| MIST | MILESTONE PHARMACEUTICALS INC | $183.11M | 85,169,344 | 40.08% | 15.52% | ||||
| XFOR | X4 PHARMACEUTICALS INC | $314.77M | 87,436,688 | 18.48% | 9.14% | Net Selling | Net Buying | ||
| DD | DUPONT DE NEMOURS INC | $17.29B | 418,975,324 | 73.21% | 1.65% | Net Selling | Net Selling | ||
| MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | $877.07M | 255,706,831 | 45.43% | 54.57% | Net Buying | Net Buying | ||
| OM | OUTSET MEDICAL INC | $67.17M | 18,153,090 | 69.36% | 30.64% | Net Selling | Net Selling | ||
| VNDA | VANDA PHARMACEUTICALS INC | $398.90M | 59,096,630 | 52.44% | 47.56% | Net Selling | |||
| LFMD | LIFEMD INC | $155.48M | 48,135,885 | 42.53% | 48.10% | Net Selling | Net Selling | ||
| DNLI | DENALI THERAPEUTICS INC | $2.47B | 146,661,833 | 60.47% | 39.53% | Net Selling | |||
| MNMD | MIND MEDICINE (MINDMED) INC | $1.25B | 98,509,279 | 40.33% | 45.46% | Net Selling | Net Selling | ||
| FANG | DIAMONDBACK ENERGY INC | $42.44B | 286,525,614 | 48.35% | 51.65% | Net Selling | Net Selling | ||
| PASG | PASSAGE BIO INC | $30.48M | 3,178,710 | 4.25% | 95.75% | Net Selling | |||
| WYFI | WHITEFIBER INC | $640.47M | 38,259,989 | 19.31% | 71.35% | Net Buying | |||
| ALMS | ALUMIS INC | $1.18B | 104,393,403 | 74.71% | 25.12% | Net Buying | Net Buying | ||
| DMAC | DIAMEDICA THERAPEUTICS INC | $441.62M | 52,077,439 | 24.49% | 71.40% | Net Buying | Net Buying | ||
| TYRA | TYRA BIOSCIENCES INC | $1.36B | 53,372,098 | 62.04% | 37.96% | Net Buying | Net Selling | ||
| KSCP | KNIGHTSCOPE INC | $42.58M | 11,508,862 | 7.54% | 71.23% | ||||
| NTGR | NETGEAR INC | $692.74M | 28,402,755 | 88.10% | 11.90% | Net Selling | Net Selling | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $193.67M | 59,500,000 | 60.11% | 0.00% | ||||
| CLYM | CLIMB BIO INC | $291.83M | 68,184,435 | 65.38% | 9.43% | Net Buying | Net Buying | ||
| ENTA | ENANTA PHARMACEUTICALS INC | $444.20M | 28,862,601 | 57.21% | 42.79% | Net Buying | Net Selling | ||
| TERN | TERNS PHARMACEUTICALS INC | $3.59B | 90,079,781 | 81.34% | 18.66% | Net Buying | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $571.86M | 59,076,259 | 55.52% | 44.48% | Net Buying | Net Buying | ||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $1.44B | 82,787,220 | 25.49% | 74.51% | Net Selling | Net Selling | ||
| VTYX | VENTYX BIOSCIENCES INC | $623.67M | 71,358,638 | 40.55% | 59.45% | Net Buying | Net Selling | ||
| MLYS | MINERALYS THERAPEUTICS INC | $2.91B | 79,139,956 | 67.79% | 32.21% | Net Buying | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.